These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38718757)

  • 21. Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway.
    Zhang XL; Wang YN; Ma LY; Liu ZS; Ye F; Yang JH
    Acta Pharmacol Sin; 2020 Mar; 41(3):383-393. PubMed ID: 31659239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling.
    Zhang D; Tong X; Arthurs B; Guha A; Rui L; Kamath A; Inoki K; Yin L
    J Biol Chem; 2014 Sep; 289(37):25925-35. PubMed ID: 25063808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly.
    Flannery C; Dufour S; Rabøl R; Shulman GI; Petersen KF
    Diabetes; 2012 Nov; 61(11):2711-7. PubMed ID: 22829450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leptin decreases de novo lipogenesis in patients with lipodystrophy.
    Baykal AP; Parks EJ; Shamburek R; Syed-Abdul MM; Chacko S; Cochran E; Startzell M; Gharib AM; Ouwerkerk R; Abd-Elmoniem KZ; Walter PJ; Walter M; Muniyappa R; Chung ST; Brown RJ
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
    Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
    Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice.
    Yao Z; Gong Y; Chen W; Shao S; Song Y; Guo H; Li Q; Liu S; Wang X; Zhang Z; Wang Q; Xu Y; Wu Y; Wan Q; Zhao X; Xuan Q; Wang D; Lin X; Xu J; Liu J; Proud CG; Wang X; Yang R; Fu L; Niu S; Kong J; Gao L; Bo T; Zhao J
    Nat Metab; 2023 Oct; 5(10):1706-1725. PubMed ID: 37735236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.
    Kuang JR; Zhang ZH; Leng WL; Lei XT; Liang ZW
    Mol Cell Endocrinol; 2017 May; 447():106-115. PubMed ID: 28237722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
    Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
    J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
    Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
    Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.
    Samuel VT; Liu ZX; Qu X; Elder BD; Bilz S; Befroy D; Romanelli AJ; Shulman GI
    J Biol Chem; 2004 Jul; 279(31):32345-53. PubMed ID: 15166226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis.
    Li S; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3441-6. PubMed ID: 20133650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling.
    Javary J; Allain-Courtois N; Saucisse N; Costet P; Heraud C; Benhamed F; Pierre R; Bure C; Pallares-Lupon N; Do Cruzeiro M; Postic C; Cota D; Dubus P; Rosenbaum J; Benhamouche-Trouillet S
    Gut; 2018 Dec; 67(12):2192-2203. PubMed ID: 29074727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease.
    Ter Horst KW; Vatner DF; Zhang D; Cline GW; Ackermans MT; Nederveen AJ; Verheij J; Demirkiran A; van Wagensveld BA; Dallinga-Thie GM; Nieuwdorp M; Romijn JA; Shulman GI; Serlie MJ
    Diabetes Care; 2021 Feb; 44(2):489-498. PubMed ID: 33293347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acylated ghrelin induces but deacylated ghrelin prevents hepatic steatosis and insulin resistance in lean rats: Effects on DAG/ PKC/JNK pathway.
    Dallak MA
    Biomed Pharmacother; 2018 Sep; 105():299-311. PubMed ID: 29860222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
    Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences.
    Hijmans BS; Grefhorst A; Oosterveer MH; Groen AK
    Biochimie; 2014 Jan; 96():121-9. PubMed ID: 23792151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.
    Ter Horst KW; Serlie MJ
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.